NACDS expresses support for 21st Century Cures bipartisan initiative
WASHINGTON — As the healthcare landscape continues to change at a rapid pace, the National Association of Chain Drug Stores is supporting a bipartisan initiative aimed at accelerating the pace of cures and medical breakthroughs in the United States.
Recently, Robert Horne, a professional staff member on the House Committee on Energy and Commerce, spoke at an NACDS-facilitated Rx 4 U.S. coalition meeting about issues, including a new initiative called 21st Century Cures, the NACDS stated.
Launched by Commerce Committee chairman Rep. Fred Upton, R-Mich., and committee member Rep. Diana DeGette, D-Colo., the initiative seeks to harness the power of technology and bring together researchers, innovators and patients in order to understand diseases better and advance research that will lead toward cures.
Describing the need for the initiative, Rep. Upton was quoted as saying, “We want to know how to close the gaps between advances in scientific knowledge about cures and the regulatory policies created to save more lives.”
To express its support of 21st Century Cures, NACDS recently submitted a letter to Reps. Upton and DeGette. To read the letter, click here.
According to NACDS, the committee will collaborate broadly with the National Institutes of Health, the Food and Drug Administration and other agencies, as well as patients and scientific researchers. Rep. DeGette said Congress will look “at the full arc of the process — from the discovery of clues in basic science, to streamlining the drug and device development process, to unleashing the power of digital medicine and social media at the treatment delivery phase.”
NACDS noted that legislators hope the multiyear collaborative effort will accelerate medical advancements and make the predominant diseases of today a thing of the past. They also have indicated an openness to including pharmacy innovation topics in the scope of the initiative’s work.
Recently, Robert Horne, a professional staff member on the House Committee on Energy and Commerce, spoke at an NACDS-facilitated Rx 4 U.S. coalition meeting about issues, including a new initiative called 21st Century Cures, the NACDS stated.
Launched by Commerce Committee chairman Rep. Fred Upton, R-Mich., and committee member Rep. Diana DeGette, D-Colo., the initiative seeks to harness the power of technology and bring together researchers, innovators and patients in order to understand diseases better and advance research that will lead toward cures.
Describing the need for the initiative, Rep. Upton was quoted as saying, “We want to know how to close the gaps between advances in scientific knowledge about cures and the regulatory policies created to save more lives.”
To express its support of 21st Century Cures, NACDS recently submitted a letter to Reps. Upton and DeGette. To read the letter, click here.
According to NACDS, the committee will collaborate broadly with the National Institutes of Health, the Food and Drug Administration and other agencies, as well as patients and scientific researchers. Rep. DeGette said Congress will look “at the full arc of the process — from the discovery of clues in basic science, to streamlining the drug and device development process, to unleashing the power of digital medicine and social media at the treatment delivery phase.”
NACDS noted that legislators hope the multiyear collaborative effort will accelerate medical advancements and make the predominant diseases of today a thing of the past. They also have indicated an openness to including pharmacy innovation topics in the scope of the initiative’s work.